Kestra Advisory Services, LLC Ionis Pharmaceuticals Inc Transaction History

Kestra Advisory Services, LLC

$14.4 Billion
Q1 2024

A detailed history of Kestra Advisory Services, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 5,550 shares of IONS stock, worth $264,513. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,550

Previous 5,040 10.12%

Holding current value

$264,513

Previous $254,000 5.51%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $21,435 - $27,310	510 Added 10.12%	5,550 $240,000
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $2,690 - $3,201	62 Added 1.25%	5,040 $254,000
Q3 2023 Nov 09, 2023	SELL	$38.5 - $47.13 $8,470 - $10,368	-220 Reduced 4.23%	4,978 $225,000
Q2 2023 Aug 11, 2023	BUY	$34.73 - $43.33 $180,526 - $225,229	5,198 New	5,198 $213,000
Q4 2022 Jan 31, 2023	SELL	$37.12 - $46.52 $19,005 - $23,818	-512 Reduced 2.23%	22,413 $846,000

Q3 2022 Nov 01, 2022	BUY	$36.54 - $48.66 $3,434 - $4,574	94 Added 0.41%	22,925 $1.01 Billion
Q2 2022 Aug 12, 2022	SELL	$31.71 - $43.0 $24,924 - $33,798	-786 Reduced 3.33%	22,831 $845,000
Q1 2022 Apr 26, 2022	BUY	$29.88 - $37.04 $117,607 - $145,789	3,936 Added 20.0%	23,617 $874,000
Q4 2021 Jan 20, 2022	SELL	$25.61 - $35.1 $211,103 - $289,329	-8,243 Reduced 29.52%	19,681 $598,000
Q3 2021 Oct 19, 2021	BUY	$33.54 - $40.55 $170,316 - $205,912	5,078 Added 22.23%	27,924 $936,000
Q2 2021 Jul 28, 2021	SELL	$34.54 - $47.25 $3,592 - $4,914	-104 Reduced 0.45%	22,846 $911,000
Q1 2021 May 10, 2021	BUY	$42.51 - $63.78 $975,604 - $1.46 Million	22,950 New	22,950 $1.03 Million

Others Institutions Holding IONS

# of Institutions

396

Shares Held

122M

Call Options Held

854K

Put Options Held

464K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $6.76B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Account

Kestra Advisory Services, LLC Ionis Pharmaceuticals Inc Transaction History